Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ACAD compared with SMMT: revenue, margins and what each company keeps, and the suppliers and customers both name
ACAD
Acadia Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
SMMT
Summit Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ACAD
Acadia Pharmaceuticals Inc
vs
SMMT
Summit Therapeutics Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
SMMT: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ACAD
4
STOK
Stoke Therapeutics
supplier
—
Neuren
unlisted
supplier
—
Single wholesale distributor
unlisted
customer
—
Third party distributors
unlisted
customer
Shared
0
No shared counterparties.
Only SMMT
4
—
Akeso, Inc. and its affiliates (collectively, "Akeso")
unlisted
supplier
—
Akeso
unlisted
supplier
—
Gortec
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
—
Dr. Zanganeh
unlisted
customer
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ACAD, solid
SMMT, dashed
ACAD
Acadia Pharmaceuticals Inc
Change
20.36
▼
−1.11%
Mkt cap
$3.5B
Revenue
$308M
Q2 FY26
Revenue
$1.1B
FY25
SMMT
Summit Therapeutics Inc.
Change
15.00
▼
−6.44%
Regular session
Nov 2 '26
Mkt cap
$12.8B
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 2 '26
ACAD
Acadia Pharmaceuticals Inc
vs
SMMT
Summit Therapeutics Inc.
20.36
▼
−1.11%
Price
15.00
▼
−6.44%
$3.5B
Mkt cap
$12.8B
Q2 FY26
$308M
Revenue
—
FY25
$1.1B
Revenue
—
Change
Change
ACAD
20.36
▼
−1.11%
vs
SMMT
15.00
▼
−6.44%
Regular session
Nov 2 '26